Two new ultrasound elastography techniques show promise for the diagnosis and characterization of breast lesions, according to researchers from France and Korea. They could complement standard gray-scale sonography, evaluate suspicious microcalcifications detected with conventional mammography, and do away with unnecessary, painful needle biopsies.
Two new ultrasound elastography techniques show promise for the diagnosis and characterization of breast lesions, according to researchers from France and Korea. They could complement standard gray-scale sonography, evaluate suspicious microcalcifications detected with conventional mammography, and do away with unnecessary, painful needle biopsies.
Dr. Alexandra Athanasiu from the Institut Curie in Paris released preliminary results of "supersonic shear wave" sonoelastography for the characterization of breast lesions at the ECR in Vienna Friday. The technique combines the "palpation" effect of the ultrasound beam with a fast imaging sequence that produces a quantitative measurement of tissue elasticity in real time. It can be done with a conventional probe and is easily reproducible and operator-independent, according to Athanasiu.
Athanasiu and colleagues prospectively assessed 36 nodules from 34 consecutive patients that were correlated with pathology results. They found supersonic shear wave imaging detected all suspicious lesions, including small isoechoic ones, and could reliably characterize benign from malignant nodules. The elasticity values of malignant lesions proved significantly different from benign ones (170 kPa versus 62 kPa, respectively). The technique also characterized correctly the cystic component of simple or complicated cysts detected by B-mode sonography.
"Supersonic shear wave sonoelastography is an innovative operator-independent technique insensible to patient movements that could be a valuable complementary tool for characterizing benign versus malignant lesions," Athanasiu said. "It can avoid unnecessary short-term follow-ups and fine-needle aspiration biopsies."
In the other study, researchers from Seoul led by Drs. Woo Kyung Moon and Nariya Cho used elastography to evaluate the difference in tissue strain associated with benign and malignant microcalcifications detected at screening mammography. They enrolled 50 consecutive women scheduled to undergo ultrasound-guided biopsies. The researchers found that breast lesions associated with malignant microcalcifications tend to demonstrate less strain than benign microcalcifications.
Two experienced radiologists blinded to mammographic and pathology findings interpreted the real-time elastograms of 50 lesions (25 ductal carcinoma in situ and 25 fibrocystic changes) and provided elasticity scores of 1 to 5 according to the degree of strain induced by light compression. Malignant lesions had a mean score of 3, while benign ones scored an average of 1.3. The difference was statistically significant (p<0.001).
"Ultrasound elastography has the potential to improve the accuracy of gray-scale sonography for the detection and differentiation of breast lesions associated with suspicious microcalcifications detected with screening mammography," Moon said.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Study Finds Transvaginal Ultrasound Unreliable for Detecting Endometrial Cancer in Black Patients
July 3rd 2024Utilizing a threshold of less than 5 mm of ultrasound-measured endometrial thickness, the authors of a new study noted an 11.4 percent false-negative probability for endometrial cancer in Black patients.
New Study Shows Non-Radiologists Interpreting 28 Percent of Imaging for Medicare Patients
June 28th 2024While radiologists interpreted approximately 99 percent of all non-cardiac CT, MRI and nuclear medicine studies in hospital and emergency department settings for Medicare beneficiaries, new research shows significantly less radiologist review of cardiac imaging and office-based imaging.
FDA Clears Pocket-Sized ECG System and AI Technology for Detection of Cardiac Conditions
June 27th 2024Using a reduced leadset and deep neural network algorithms trained on more than 175 million electrocardiograms, the KAI 12L technology reportedly detects up to 35 cardiac determinations, including acute myocardial infarction.